GARDP set up as independent legal entity

The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun working with partners to develop antibiotics to tackle drug-resistant infections which pose a threat to global health and development, including the achievement of the Sustainable Development Goals.

Article: GARDP

Smart Innovations  
Back


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed